The new understanding promises to have a major impact on drug discovery efforts.
The findings from the Oldstone and Rosen labs also clarify the workings of a potent new class of anti-inflammatory compounds that prevent this immune overreaction in animal models.
At a lecture at TSRI February 25, GNF Director H. Martin Seidel noted there are plentiful opportunities to collaborate.